Get the latest Science News and Discoveries

FDA approves Moderna's new COVID-19 vaccine

The company's "next-generation" COVID-19 vaccine, mNexspike, was approved for adults 65 and older and younger people at risk of severe disease.

None

Related news:

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction – historic milestone for women’s health - EurekAlert!

At-home heart attacks and cardiac deaths on the rise since COVID-19 pandemic - EurekAlert!

U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine